Hemophilia Advisory Board
Steven Pipe, MD
PROFESSOR OF PEDIATRICS AND PATHOLOGY, MEDICAL DIRECTOR OF THE PEDIATRIC HEMOPHILIA AND COAGULATION DISORDERS PROGRAM AT THE UNIVERSITY OF MICHIGAN
Prof. Pipe completed his undergraduate medical training at the University of Toronto, Ontario, Canada, and his pediatric training at McMaster University in Hamilton, Ontario. His pediatric hematology and oncology training was completed at the University of Michigan.
*** PI in UniQure clinical trial, involved in BioMarin clinical trial
Glenn Pierce, MD, PhD
Board Director at the US National Hemophilia Foundation and World Federation of Hemophilia
Dr Pierce received both MD and PhD from Case Western Reserve University in Cleveland, Ohio and conducted postgraduate research in pathology and hematology research at Washington University in St. Louis, Missouri.
*** He has over 35 years’ successful biopharma R&D experience in protein and gene therapies, including executive positions at Biogen, Bayer and Amgen.
Mark A. Kay, MD, Ph.D
DENNIS FARREY FAMILY PROFESSOR IN DEPARTMENT OF PEDIATRICS, PROFESSOR OF GENETICS, STANFORD UNIVERSITY
Prof. Kay is the Dennis Farrey Family Professor and the Associate Chair for Basic Research in the Department of Pediatrics, Professor of Genetics and the Head of the Division of Human Gene Therapy at the Stanford University’s School of Medicine.